56 F
New York
Friday, November 27, 2020

TAG

FDA

There Could be More Rips Ahead for Bioelectronics Corp (OTCMKTS:BIEL)

Bioelectronics Corp (OTCMKTS:BIEL), as we predicted, has received pre-submission FDA approval for its ActiPatch back pain product for muscoskeletal pain. BIEL is up over...

Bioelectronics Corp (OTCMKTS:BIEL) Soars Ahead of FDA Meeting

Bioelectronics Corp (OTCMKTS:BIEL) is soaring up the charts. BIEL is up +200% over the last month and the volume is just as impressive topping...

Abattis Bioceuticals Corp (OTCMKTS:ATTBF) is Fighting a Technical Battle

Abattis Bioceuticals Corp (OTCMKTS:ATTBF) has been in a technical battle to hold onto support at its rising 200-day simple moving average in the $0.23/share...

Arch Therapeutics Inc (OTCMKTS:ARTH) Struggles After FDA Announcement

Arch Therapeutics Inc (OTCMKTS:ARTH) shares disappeared from upper range reaches this week in a sharp downward gapping move that was accompanied by very high...

ALR Technologies Inc (OTCMKTS:ALRT) Explodes Onto the Scene

ALR Technologies Inc (OTCMKTS:ALRT) is a bottle rocket on the OTC that will probably be one of the key focus plays for traders in...

Second Sight Medical Products Inc (NASDAQ:EYES) Starts To Open Some Eyes

Second Sight Medical Products Inc (NASDAQ:EYES) is potentially an extraordinarily interesting stock. EYES Shares have been beaten down badly, but this company is working...

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) Soaring on FDA Approval

Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is a micro-cap stock that has started to engage some major eyeballs among traders and investors focused on new growth...

Biostage Inc (NASDAQ:BSTG) Bullish Reversal In Progress

Biostage Inc (NASDAQ:BSTG) technical's are rapidly improving, and its music to the ears of long term shareholders. BSTG is coming back from a poor 2016...

22nd Century Group Inc (NYSEMKT:XXII) Up on FDA Nicotine Reduction News

22nd Century Group Inc (NYSEMKT:XXII) shares took off in Friday morning gaining around 30 cents by the end of trading. XXII is a plant biotech...

Arch Therapeutics Inc (OTCMKTS:ARTH) Makes Good on Strategic Plan

Arch Therapeutics Inc (OTCMKTS:ARTH) has been back on the warpath in recent action, ripping as much as 40% higher in the past month on...

Latest news

Juniper Networks Inc. (NYSE:JNPR) Stock is Plummeting, Here is Why

Juniper Networks Inc. (JNPR) shares are trading at lower $22.04 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Chindata Group Holdings Limited (CD)’s Stock is Jumping, Here is Why

Chindata Group Holdings Limited (CD) shares are trading at higher $18.94. To add more color to this target, the company’s high over the last...

Can We Expect More Volatility From BOQI International Medical Inc. (BIMI)?

BOQI International Medical Inc. (BIMI) shares are trading at higher $2.09. To add more color to this target, the company’s high over the last...

When Will Diffusion Pharmaceuticals Inc. (DFFN) Slow Down

Diffusion Pharmaceuticals Inc. (DFFN) shares are trading at higher $0.78. To add more color to this target, the company’s high over the last year...

EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) is Gaining Momentum on Earnings Catalyst

EyePoint Pharmaceuticals Inc. (EYPT) shares are trading at higher $0.47 and the avg recommendation for the stock is Moderate Buy. To add more color...